Estrogen receptor ligands.: II.: Discovery of benzoxathiins as potent, selective estrogen receptor α modulators

被引:92
作者
Kim, S
Wu, JY
Birzin, ET
Frisch, K
Chan, W
Pai, LY
Yang, YT
Mosley, RT
Fitzgerald, PMD
Sharma, N
Dahllund, J
Thorsell, AG
DiNinno, F
Rohrer, SP
Schaeffer, JM
Hammond, ML
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Atherosclerosis, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Endocrinol, Rahway, NJ 07065 USA
[4] Karo Bio AB, Novum, S-14157 Huddinge, Sweden
关键词
D O I
10.1021/jm034243o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery and synthesis of dihydrobenzoxathiins as potent, ERalpha subtype selective ligands are described. The most active analogue, 4-D, was found to be 50-fold selective in a competitive binding assay and 100-fold selective in a transactivation assay in HEK-293 cells. The a selectivity was postulated to lie in the interaction of the sulfur atom of the benzoxathiin ring with the two discriminating residues in the binding pocket of the receptor isoforms.
引用
收藏
页码:2171 / 2175
页数:5
相关论文
共 21 条
[1]   SYNTHESIS OF 3-ARYL-1,4-BENZOXATHIANES - APPLICATION TO THE PREPARATION OF A SWEET COMPOUND [J].
ARNOLDI, A ;
BASSOLI, A ;
CAPUTO, R ;
MERLINI, L ;
PALUMBO, G ;
PEDATELLA, S .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1994, (09) :1241-1244
[2]  
CHEN HY, IN PRESS BIOORG MED
[3]   Structure-activity relationships of selective estrogen receptor modulators: Modifications to the 2-arylbenzothiophene core of raloxifene [J].
Grese, TA ;
Cho, S ;
Finley, DR ;
Godfrey, AG ;
Jones, CD ;
Lugar, CW ;
Martin, MJ ;
Matsumoto, K ;
Pennington, LD ;
Winter, MA ;
Adrian, MD ;
Cole, HW ;
Magee, DE ;
Phillips, DL ;
Rowley, ER ;
Short, LL ;
Glasebrook, AL ;
Bryant, HU .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (02) :146-167
[4]   Molecular determinants of tissue selectivity in estrogen receptor modulators [J].
Grese, TA ;
Sluka, JP ;
Bryant, HU ;
Cullinan, GJ ;
Glasebrook, AL ;
Jones, CD ;
Matsumoto, K ;
Palkowitz, AD ;
Sato, M ;
Termine, JD ;
Winter, MA ;
Yang, NN ;
Dodge, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :14105-14110
[6]   Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents [J].
Jordan, VC .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1081-1111
[7]   Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions [J].
Jordan, VC .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) :883-908
[8]   Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus, and body composition in rat models [J].
Ke, HZ ;
Paralkar, VM ;
Grasser, WA ;
Crawford, DT ;
Qi, H ;
Simmons, HA ;
Pirie, CM ;
Chidsey-Frink, KL ;
Owen, TA ;
Smock, SL ;
Chen, HK ;
Jee, WSS ;
Cameron, KO ;
Rosati, RL ;
Brown, TA ;
Dasilva-Jardine, P ;
Thompson, DD .
ENDOCRINOLOGY, 1998, 139 (04) :2068-2076
[9]   Dehydrative reduction:: A highly diastereoselective synthesis of syn-bisaryi(or heteroaryl) dihydrobenzoxathiins and benzodioxane [J].
Kim, S ;
Wu, JY ;
Chen, HY ;
DiNinno, F .
ORGANIC LETTERS, 2003, 5 (05) :685-688
[10]   Cloning of a novel estrogen receptor expressed in rat prostate and ovary [J].
Kuiper, GGJM ;
Enmark, E ;
PeltoHuikko, M ;
Nilsson, S ;
Gustafsson, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5925-5930